The global poultry vaccines market share in 2026 size was valued at USD 1.32 billion in 2025 and is projected to grow from USD 1.38 billion in 2026 to USD 2.38 billion by 2034, exhibiting a CAGR of 6.99% during the forecast period. North America dominated the poultry vaccines market with a market share of 46.11% in 2025. The market is expanding as poultry producers increasingly focus on disease prevention, flock health, and biosecurity to support the growing demand for poultry meat and eggs.
Poultry vaccines play an important role in protecting birds against infectious diseases, including avian influenza, Newcastle disease, and Marek’s disease. Vaccination programs help poultry producers manage disease risks, maintain flock productivity, and reduce potential economic losses associated with outbreaks. Growing awareness of preventive animal healthcare and investments by manufacturers in vaccine research and development are also contributing to market expansion.
Top Companies In The Market
- Elanco (U.S.)
- Boehringer Ingelheim International GmbH (Germany)
- Virbac (France)
- Merck & Co., Inc. (U.S.)
- Zoetis Services LLC (U.S.)
- Ceva (France)
- Bioveta, a.s. (Czech Republic)
- Indian Immunologicals Ltd. (IIL) (India)
- HIPRA (Spain)
The market includes established animal health companies that focus on product development, vaccine launches, and geographic expansion. Zoetis Services LLC, Merck & Co., Inc., and Boehringer Ingelheim International GmbH are among the prominent participants. Competition is shaped by vaccine portfolios, research and development activities, and efforts to improve disease prevention across poultry populations.
Market Drivers & Restraints:
Market Drivers
- Rising consumption of poultry meat and eggs: Growing demand for animal-based protein increases the importance of maintaining healthy poultry flocks. Vaccination supports disease prevention and helps producers maintain a consistent supply of poultry products.
- Increasing incidence of infectious poultry diseases: Outbreaks of avian influenza, Newcastle disease, and other infections encourage poultry farmers to strengthen vaccination programs and improve biosecurity practices.
- Greater awareness of preventive animal healthcare: Poultry producers are increasingly emphasizing disease management and flock health to limit the operational and financial effects of infectious diseases.
- Research and development initiatives: Manufacturers are investing in new vaccine technologies and product launches to address poultry disease risks and improve preventive healthcare options.
Market Restraints
Vaccine failure and inconsistent protection can restrict market growth. Some poultry diseases may continue to affect vaccinated flocks, particularly when disease-causing agents change or vaccination programs do not provide sufficient protection. These situations can lead to economic losses and reduce producers’ confidence in vaccination strategies.
Storage and transportation requirements also present challenges. Poultry vaccines generally require controlled temperatures to preserve their effectiveness. Maintaining the cold chain during distribution and on-farm handling can be difficult, particularly for smaller producers with limited infrastructure. Improper storage may reduce vaccine quality and compromise immunization outcomes.
Market Competitive Landscape:
The poultry vaccines market features a range of international animal health companies competing through product development, portfolio expansion, and geographic reach. Leading participants seek to strengthen their positions by introducing vaccines targeting important poultry diseases and expanding access to preventive healthcare solutions.
Product innovation remains an important competitive factor. In November 2024, Vaxxinova received European Commission marketing authorization for Vaxxon ND Clone, a vaccine intended to prevent Newcastle disease in poultry. Other industry developments highlighted in the market include vaccine launches, acquisitions, and initiatives to improve poultry disease prevention. These activities reflect continuing efforts to address disease risks and meet the needs of poultry producers across different markets.
Strategic expansion and research and development are expected to remain important as companies respond to changing disease challenges and growing demand for poultry products. The competitive environment also places emphasis on developing effective vaccines and supporting their appropriate use through established distribution channels.
Market Segments:
The poultry vaccines market is segmented by
By Technology (Inactivated, Live Attenuated, Recombinant, and Others)
By Disease Type (Viral Diseases {Avian Influenza, Newcastle Disease, Marek’s Disease, and Others}
Bacterial Diseases {Salmonellosis, Mycoplasmosis, and Others}, and Parasitic Diseases)
By Route of Administration (Parenteral, Intranasal, and Others)
By Distribution Channel (Veterinary Hospitals, Veterinary Clinics, Pharmacies & Drug Stores, and Others)
Explore the full research report with detailed insights and TOC: https://www.fortunebusinessinsights.com/poultry-vaccines-market-113875
Market Regional Insights:
North America
North America dominated the poultry vaccines market in 2025, generating USD 0.61 billion and accounting for 46.11% of global revenue. The regional market is projected to reach USD 0.64 billion in 2026. Its leading position is supported by vaccination guidelines, poultry health monitoring systems, and the presence of established animal health companies offering poultry vaccines. Research funding and efforts to develop vaccines against avian influenza also contribute to regional market activity.
Europe
Europe generated USD 0.36 billion in 2025, representing 27.47% of the global market, and is projected to reach USD 0.38 billion in 2026. Demand for poultry products and continued attention to flock health support the regional market. Vaccine development and product authorization also contribute to the availability of preventive solutions for poultry diseases.
Asia Pacific
Asia Pacific accounted for USD 0.18 billion in 2025, representing 13.46% of the global market, and is projected to reach USD 0.19 billion in 2026. Increasing attention to poultry disease prevention and food safety supports the market. Japan’s focus on food safety standards and advanced poultry health management also contributes to regional development.
Future Market Scope:
The future of the poultry vaccines market will be influenced by demand for poultry meat and eggs, the need to control infectious diseases, and continued investment in preventive animal healthcare. Government vaccination initiatives may create opportunities to expand immunization coverage and address disease outbreaks that affect poultry production and trade. In-ovo vaccination is an important industry trend. This approach involves administering vaccines to embryos during incubation, helping hatcheries manage vaccination across large numbers of birds while reducing the need for individual handling after hatching.
What Everyone Should Know About Japan’s Market -Poultry Vaccines Market- Insights